The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate

The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate

Source: 
Yahoo/Benzinga
snippet: 

Biotech stocks moved mostly sideways during the week, although there was a flurry of activity in the space. Earnings from the sector began to trickle in, with Bristol-Myers Squibb Co (NYSE: BMY) reporting forecast-beating earnings.